Search

everythinglearnresearchcommunity

for

Search:↓

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

Electrospun scaffolds can improve healing in diabetic wounds.

Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Human placenta hydrolysates help treat various diseases and aid healing.

Autologous platelet concentrates can effectively treat oral lichen planus like topical steroids.

Medicinal plants might help with post-COVID-19 issues, but more research is needed.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

FFA has higher long-term remission rates than LPP.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Baricitinib is an effective treatment for severe alopecia areata.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

Microneedles could make it easier and less painful to deliver more types of drugs through the skin.

Continuous use of finasteride and minoxidil is effective for treating androgenetic alopecia.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Managing stress and nerve activity can help treat segmental vitiligo and white hair.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.